Pravastatin is a medication belonging to the statin class, primarily used to lower high cholesterol levels and reduce the risk of cardiovascular events such as heart attacks and strokes. It is commercially known by its brand name, Pravachol. While it shares the general mechanism of action with other statins, pravastatin distinguishes itself through its hydrophilic (water-soluble) nature, which may influence its tissue distribution and potential for certain side effects compared to lipophilic (fat-soluble) statins. This characteristic can be relevant in specific patient populations.
The development of statins, including pravastatin, marked a significant advancement in the management of dyslipidemia and the prevention of atherosclerotic cardiovascular disease. Pravastatin was approved by the FDA based on extensive clinical trials demonstrating its efficacy and safety profile. It is typically prescribed as part of a comprehensive cardiovascular risk reduction strategy that includes dietary changes, exercise, and other lifestyle modifications. The medication is available in oral tablet form and is taken once daily.
Deep dive
Tap a section to expand.
Known interactions
Category rule: supplement × medication
Note
Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).
Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Category rule: vitamin × medication
Note
Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).
Specific pairs are checked against a licensed source; confirm with your provider.
Compound-pair rule
Caution
Berberine inhibits CYP3A4 and P-glycoprotein, raising statin levels and myopathy risk.
Separate dosing and monitor for muscle pain; consider lower statin dose.
Compound-pair rule
Caution
Berberine inhibits CYP3A4 and P-glycoprotein, raising statin levels and myopathy risk.
Separate dosing and monitor for muscle pain.
Compound-pair rule
Synergy
Statins block CoQ10 biosynthesis via the mevalonate pathway; supplementing may reduce muscle symptoms.
Consider 100–200 mg CoQ10 daily while on a statin.
Compound-pair rule
Synergy
Statins deplete CoQ10; ubiquinol replenishes it.
Consider 100 mg ubiquinol daily.
Frequently asked
Sources referenced
["Mayo Clinic","National Institutes of Health (NIH) - MedlinePlus","DrugBank","U.S. Food and Drug Administration (FDA) - Drug Label","PubChem","Cochrane Library","American College of Cardiology (ACC)"]
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the medication category or studied for the same goals.